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As an alternative, Speakman has 
put forward a non-adaptive scenario — 
the drifty gene hypothesis. According 
to this idea, genetic drift — the change 
of gene frequencies due to random, 
non-selective processes— could 
explain the current incidence of 
obesity seen in modern, industrialized 
populations. Speakman has 
hypothesized that the threat of 
predation on early humans may have 
provided a strong selective pressure 
to keep maximum body weight in 
check. A human fleeing from a saber-
tooth cat, for example, would be at 
a clear disadvantage if they carried 
extra weight. The introduction of fire 
and cooperative social groups may 
have reduced the threat of predation, 
allowing upper body weight to wander 
through genetic drift. The effects of 
genetic drift are most profound in 
small populations, but Speakman 
argues that just such a process could 
explain the accumulation of mutations 
in the human population that affect 
body weight.
Future outlook
Testing ideas such as the thrifty and 
drifty gene hypotheses will depend 
greatly on a better understanding of 
the genetic basis of obesity. There is 
no doubt that genetics factors heavily, 
as it is has been estimated that 
40–70% of the variability in body-mass 
index can be explained by genetic 
differences. As in other polygenic traits 
studied, however, the contribution of 
the few genes identified appear to be 
rather small. Such genes, satisfyingly, 
appear to be involved in the signaling 
pathways that control feeding and 
energy storage. As more genes are 
identified, it will be interesting to see 
if there is any evidence that natural 
selection has operated on obesity 
genes or whether, if Speakman is 
correct, neutral evolutionary processes 
were at work. However, given that 
most genes have many different 
functions, the existence of such 
genes in the population may after all 
also reflect selection on a completely 
different trait than body mass.
Whatever progress is made on 
the genetics of obesity, it is clear 
that environmental factors are 
equally crucial. That obesity was 
rare in the US and elsewhere nearly 
a century ago makes this obvious. 
Something in our environment 
has conspired with our genes to 
produce the current situation. As 
noted, the animal work suggests 
that the influx of energy-dense 
food, characterized by high fat and 
refined sugars, is likely to induce 
obesity. But what about the claim 
that our couch-potato lifestyle is a 
contributing factor? Surprisingly, 
recent research calls this idea 
into doubt. In June, a paper from 
Pontzer and colleagues (PLoS ONE 
(2012) 7, e40503) reported that the 
average daily energy expenditure 
of a hunter-gather group, the Hadza 
people living in East Africa, is not 
significantly different from that of 
numerous industrialized populations, 
including Americans. This is despite 
the fact that the Hadza, as expected, 
are much more physically active than 
their western counterparts.
 Why this should be is uncertain, 
but if the results hold up, it suggests 
that diet rather than physical activity 
may be a more important component 
of obesity. Sadly, this is consistent 
with the demographics of obesity, 
as the poor, for whom a high-fat diet 
is the cheapest option, exhibit the 
highest rates of obesity. In some ways 
it seems we are a victim of our own 
success. Advances in agriculture 
and food processing has brought an 
abundance of cheap food to the table. 
Thus, while many in the world are 
malnourished, industrialized nations 
have swung to the other extreme, 
but in the process we have forgotten 
that the quality of the food is just as 
important as the quantity.
Turning back to the question of 
the link between our evolutionary 
history and obesity, there are no clear 
answers as yet. We do know that 
humans have evolved in response to 
the food in their environment. What’s 
less clear is whether obesity is best 
seen as a discordance between 
previous adaptations and our modern 
environment, as in sickle cell anemia. 
There is certainly scope for such 
disharmony. In particular, our modern 
culture is changing so quickly, it’s 
difficult to imagine how evolution could 
keep up, especially given that modern 
medicine undoubtedly reduces the 
main agent of evolution — natural 
selection. While frightening for most 
people, perhaps this scenario is 
comforting for those that have always 
wished for a simpler life, free of Big 
Macs, escalators, and work cubicles.
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Research suggests that the rapid 
population growth of our species in 
the last 10,000 years has produced 
a kind of genetic variability for which 
traditional models of population 
genetics are inadequate. But do 
the new findings solve the missing 
heritability problem emerging from 
genome-wide association studies? 
And does the phenomenon put our 
species at risk? Michael Gross 
investigates. 
The ongoing ‘genome revolution’ 
has had no shortage of discoveries. 
New methods like genome-wide 
association studies (GWAS) have 
raked in hundreds and thousands of 
associations between genetic traits 
and medically relevant phenotypes in 
the last five years. From the headlines 
reporting new discoveries, one would 
think that we are living in a golden age 
of medical research and all our ills will 
become curable very soon. 
However, a much more sober 
view prevails as soon as one looks 
at a specific disorder and sums up 
which fraction of the case number 
is accounted for by the genetic 
discoveries. In autism, for instance, 
the genes linked to the condition 
so far only explain a single figure 
percentage of the cases, even 
though twin studies suggest that 
the heritability is much higher (Curr. 
Biol. (2011) 21, R571–R573). A similar 
situation is observed for all other 
complex diseases that have genetic 
contributory factors, including 
cancers, diabetes, and heart disease. 
Epigenetics may explain part of 
the heredity that does not show up in 
linkage studies, and combinations of 
frequent mutations that individually 
only have very weak effects may 
also play a role. However, recent 
discoveries have pointed a spotlight 
on a possible explanation that has so 
far been underappreciated: mutations 
that are so rare that they fell through 
the grid in the first systematic 
searches for medically relevant 
polymorphisms. 
abundance of rare variants
Several studies published this year 
have pointed to a surprisingly high 
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Fair game: When humans first abandoned the hunter-gatherer lifestyle and embraced 
agriculture, the advance started a population expansion that shapes human population 
genetics to this day. (Photo: Raul Martin/MSF/Science Photo Library.)number of rare variations in the 
human genome, which are defined 
as variations that affect less than 
0.5% of individuals in a population. 
By contrast, previous studies of 
human genetic diversity have 
typically focused on variants that 
affect at least 1% of the population, 
such as SNPs (single nucleotide 
polymorphisms). 
In February, an international 
collaboration led by Daniel MacArthur 
at the Sanger Institute near 
Cambridge, UK, surveyed variants in 
protein-coding genes that lead to loss 
of protein function (Science (2012), 
335, 823–828). The authors calculated 
that a typical human genome will 
contain around 100 loss-of-function 
variants, and around 20 genes will 
be knocked out completely. They 
conclude that the human genome 
must be more robust towards gene 
disruption than had been previously 
thought. 
In May, Alon Keinan and Andrew 
Clark from Cornell University linked 
the high number of rare variants 
to the rapid population growth 
in the last 10,000 years (Science 
(2012) 336, 740–743). Following the 
introduction of agriculture, the world 
population grew by more than three 
orders of magnitude in less than 400 
generations. In the last 1,000 years, 
growth was even faster with one 
doubling every 10 generations, and 
the growth rate peaked in 1962–1963 
with 2.2% per annum. For population 
genetics, the ‘effective population 
size’ is the crucial parameter, which 
is typically smaller than the actual 
number of individuals, but which has 
grown just as dramatically in the last 
10,000 years. 
The 1,000-year measure of one 
doubling per ten generations may 
not seem extreme if you consider 
individual families, which may 
grow much faster. However, as a 
sustained expansion across the whole 
population it is sufficient to derail 
current models of population genetics 
that rely on a steady-state situation, 
and on which previous analysis of 
human genetic diversity and disease 
patterns had been based. 
“Everybody was obviously aware 
of the recent growth of human 
populations, but the effects on 
patterns of genetic variation have not 
been incorporated — till the recent 
series of papers — into models,” 
explains Keinan. “The main reason is that thus far researchers have been 
only able to consider relatively small 
samples of individuals, in which the 
effects of growth are not apparent. 
There are theoretical population 
genetic models that account for 
exponential population growth, 
but these are not applicable to a 
scenario in which the exponential 
growth starts only in relatively recent 
history, after a period characterized 
by less fluctuation in population size. 
This scenario raises new modelling 
challenges.”
The rapid population growth of 
the human race was preceded and 
accompanied by its spread across 
a broad variety of habitats, from the 
tropics to the polar regions, during the 
last 100,000 years. The extent to which 
the diversity of human phenotypes 
reflects adaptation to the different 
habitats is still being investigated, as 
Jonathan Pritchard from the University 
of Chicago has reported in a recent 
review in this journal (Curr. Biol. (2010), 
20, R208–R215). 
In that time frame, additional 
layers of complexity come in with the 
evolutionary history of our species 
and the questions surrounding 
admixture of related subspecies such 
as Neanderthals and Denisovans. 
While the first analysis of the 
Neanderthal genome suggested that non-Africans carry up to 4% 
Neanderthal DNA (see Curr. Biol. 
(2011), 21, R872), a recent publication 
has challenged that figure (Proc. 
Natl. Acad. Sci. USA (2012) 109, doi: 
10.1073/pnas.1200567109).
Two further studies published in 
July highlighted the abundance of rare 
mutations in the human genome. A 
sequencing consortium led by Michael 
Bamshad and Joshua Akey at the 
University of Washington at Seattle 
sequenced the largest part of the 
protein-coding genes (i.e. the exome) 
of 2,440 individuals of either African 
or European ancestry (Science (2012) 
337, 64–69). They discovered more 
than half a million single-nucleotide 
variants, of which 86% were rare 
in that their frequency was below 
0.5%. They predict that more than 
300 proteins per genome would be 
affected. 
Using demographic modelling, 
they attribute this high number of 
rare variants to the rapid population 
growth. The models pinpoint the 
onset time for the relatively recent 
population explosion responsible for 
the phenomenon to around 5,000 
years ago. The analyses also show 
that linking any such mutations to 
complex diseases will require the 
sequencing of much larger numbers 
of genomes. 
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Random colours: Sequencing of protein-coding genes of large numbers of individuals 
has shown that human genomes contain many more rare variants than researchers had 
anticipated. The image shows a computer screenshot of sequenced DNA with the four 
bases colour-coded green, red, yellow and blue. (Photo: Patrick Landmann/Science Photo 
Library.)In a separate paper that appeared 
simultaneously, the groups of 
Matthew Nelson at GlaxoSmithKline 
and John Novembre at the University 
of California at Los Angeles analysed 
rare variants in a larger number 
of people focusing on a smaller 
number of genes (Science (2012) 
337, 100–104). Specifically, they 
sequenced 202 genes coding for 
drug targets in more than 14,000 
individuals. 
They also find a remarkably large 
number of variants, with every 17th 
base being affected. More than 
95% of them were below the 0.5% 
threshold defining rare variants. 
These are typically restricted 
to local populations, indicating 
that much larger and population-
specific association studies will be 
necessary to link such variants to 
diseases. 
Both studies also point to rapid 
population expansion and relatively 
weak selection as a cause of 
the high variability. “With more 
individuals in the population due to 
recent rapid human growth, there 
have been more opportunities for 
mutations to arise in the recent 
past. The resulting variants are 
young and very rare, and we only 
see them with large sample sizes,” 
Novembre explains. Weak selection, 
he says, means “that variants that 
are not immediately removed from 
a population will typically be kept at 
low frequencies.”Mind the gap
But does the discovery of genetic 
variability that had so far remained 
hidden and its attribution to the 
rapid population expansion in the 
last 10,000 years help to solve the 
missing heritability problem for 
complex diseases? So far, there 
have been three main schools of 
thought on this problem, favouring 
either rare mutations, or low-impact 
common mutations, or combinations 
of additional factors such as 
epigenetic regulation as the most 
likely area where an explanation may 
be found. 
Experts agree that the recent 
findings have strengthened the 
case for looking more closely at 
rare mutations in the quest for an 
explanation. “Appreciation of the 
population expansion provides 
higher likelihood of the hypothesis 
that many different rare variants 
contribute to complex disease 
risk,” says Alon Keinan. “This, 
in turn, might explain why so far 
the explanation gap has been as 
large as it is, given that genome-
wide association studies to date 
considered mostly common variants. 
It also entails that different methods, 
some of which are already being put 
into place, are needed to be able to 
associate rare variants with disease 
risk or other traits, but in any case 
associating rare risk variants is a 
much taller order than associating 
common variants; as they are rare, a larger sample size is needed to 
observe them, and a much reduced 
statistical power is expected for 
variants only observed in a few 
copies.”
While researchers agree that the 
importance of rare variants has 
risen, it is difficult to predict where 
the balance between the different 
influences will ultimately be found. 
“My personal intuition is that rare 
variants will make a significant 
contribution to human phenotypic 
variation, but I do not feel comfortable 
hazarding a guess as to what 
‘significant’ will turn out to be,” says 
Joshua Akey from the University of 
Washington. 
New technologies are promising 
further insights into the complexities 
of human genetic diversity. “One 
other point is that there is a 
third class of variant that people 
are chasing now with the next 
generation of target arrays that 
contain ‘all’ of the variation for 
metabolism or immunology typed 
at variants down to 1% minor allele 
frequency,” Greg Gibson from the 
Georgia Institute of Technology 
at Atlanta points out. “This is the 
so-called ‘goldilocks’ variation, 
moderate effects at low frequency. 
Rare variants of large effect are 
popping out of resequencing 
studies; GWAS found common 
variants of small effect; in between 
we expect the goldilocks variants 
may fill in some of the missing 
heritability. The metabochip and 
immunochip are being applied 
to samples in the hundreds of 
thousands for a wide range of 
diseases now.”
For specific diseases, the role 
of rare variants may even be 
impossible to quantify, warns Jaume 
Bertranpetit from the Universitat 
Pompeu Fabra at Barcelona, 
Spain. “If the variant is rare, as all 
inferences are statistic, based on 
variants of susceptibility, we need 
the power given by numbers,” 
Bertranpetit explains. “In rare 
variants we may never have enough 
cases with or without the variant to 
claim an association: sample sizes 
should be huge and maybe there are 
not enough cases. And there is an 
additional problem: the bigger the 
sample size, the more heterogeneous 
the population will be, both for cases 
and controls, and thus there will 
be more population stratification, 
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Population growth: Although the number of individuals can easily rise to more than double 
from one generation to the next in specific families, models of population genetics based 
on a steady state across the whole population regard a doubling of numbers within ten 
generations as extremely rapid expansion. (Photo: Katrina Wittkamp/The Image Bank/Getty 
Images.)
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The relative simplicity of Aplysia’s 
nervous system and the ease with 
which changes in its identified neurons 
can be shown to participate in specific 
behavioral changes have enabled 
a rich series of discoveries about 
fundamental mechanisms of neuronal 
plasticity. In addition, the clear, direct 
link between neuronal plasticity 
in Aplysia and behavior frequently 
enables insights into functional roles 
of cellular and molecular processes 
that would otherwise be missed. 
Researchers studying simpler model 
systems such as Aplysia frequently 
put their research in the context of the 
challenges of understanding human 
diseases and suggest that insights 
gained in these more readily analysable 
systems may ultimately lead to 
advances in the treatment of clinical 
disorders. For example, in describing 
a novel molecular mechanism that 
underlies an attention-like process 
in Aplysia, which was understood 
precisely because of the direct link 
between synaptic plasticity and 
behavior, we recently suggested that 
this mechanism may also contribute 
to attentional processes in mammals 
[1]. The link between basic biology 
and disease is epitomized by the 
transcription factor CREB. The initial 
For decades, the marine snail Aplysia 
has proven to be a powerful system 
for analyzing basic neurobiological 
mechanisms, particularly cellular 
and molecular mechanisms of 
neural plasticity. Three new findings 
on Aplysia may be relevant for 
the understanding and treatment 
of chronic human disorders. This 
research on this simple molluscan 
nervous system may lead to new 
therapeutic approaches for spinal 
cord injury, Fragile X syndrome, 
and genetic learning deficits more 
generally. 
Studies on Aplysia 
neurons suggest 
treatments for 
chronic human 
disorderswhich is known to give false positive 
results.”
Bad for our health? 
The recent papers have also shown 
that a surprisingly large number of 
the newly discovered rare variants 
actually affect the function of the 
corresponding gene products. 
However, Greg Gibson cautions that 
the results can’t tell us yet “whether 
these rare variants are promoting 
disease disproportionately, because 
we really have little idea about how 
variable their effects, or those of 
common variants, are among people. 
Evolutionary and structural inference 
suggests that many of them are likely 
to be deleterious, but we have to keep 
in mind that there is an enormous 
capacity of the genome to buffer the 
effects of variation.” 
Some have warned that the 
continuing accumulation and spread 
of deleterious mutations could 
spell trouble for the health of future 
generations. For instance, Michael 
Lynch from Indiana University at 
Bloomington, US, used his inaugural 
article as a new member of the 
National Academy of Sciences (Proc. 
Natl. Acad. Sci. USA (2010) 107, 
961–968) to warn “that a substantial 
reduction in human fitness can be expected over the next few centuries 
in industrialized societies unless novel 
means of genetic intervention are 
developed.”
Other researchers have concluded 
that, quite on the contrary, the 
presence of large numbers of variants 
in healthy individuals shows that 
the human genome has a level of 
robustness towards disease that 
has so far been underappreciated. 
Greg Gibson has described this 
phenomenon as ‘decanalisation’ 
based on the concept from population 
genetics, where individuals in a 
canalised population tend to stay very 
close to the optimal phenotype (Nat. 
Rev. Genet. (2009) 10, 134–140). 
The majority view seems to be that 
genetic meltdown isn’t imminent yet. 
“Many of these arguments rely on 
the concept of genetic load, which 
can be parameterized in different 
ways, giving potentially different 
results,” says Joshua Akey. “It 
seems to me, if we want to worry 
about human extinction, we should 
be more concerned about climate 
change, wars, and other man-made 
problems.”
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